Also Known As
Follow this Page for updates
The dosages of Gamma-oryzanol used are highly variable, with some studies using a lower dose (50mg once daily or 20mg thrice daily) and other studies using a markedly higher dosage (300-800mg daily). As there are no reliable benefits associated with Gamma-oryzanol supplementation in the first place, it is unsure what dosage should be recommended (if this supplement is to be recommended at all).
Your e-mail is safe with us. We don’t share personal data.
The Human Effect Matrix looks at human studies (it excludes animal and in vitro studies) to tell you what effects gamma oryzanol has on your body, and how strong these effects are.
|Grade||Level of Evidence|
|Robust research conducted with repeated double-blind clinical trials|
|Multiple studies where at least two are double-blind and placebo controlled|
|Single double-blind study or multiple cohort studies|
|Uncontrolled or observational studies only|
Level of Evidence
? The amount of high quality evidence. The more evidence, the more we can trust the results.
Magnitude of effect
? The direction and size of the supplement's impact on each outcome. Some supplements can have an increasing effect, others have a decreasing effect, and others have no effect.
Consistency of research results
? Scientific research does not always agree. HIGH or VERY HIGH means that most of the scientific research agrees.
|Cortisol||-||- See study|
|Estrogen||-||- See study|
|Growth Hormone||-||- See study|
|HDL-C||-||Very High See 2 studies|
|Insulin||-||- See study|
|LDL-C||-||- See study|
|Plasma Endorphins||-||- See study|
|Power Output||-||- See study|
|Testosterone||-||- See study|
|Total Cholesterol||-||Very High See 2 studies|
|Triglycerides||-||- See study|
Your e-mail is safe with us. We don’t share personal data.
Gamma-oryzanol is most well known for being a component of Rice Bran Oil as well as rice itself and is credited alongside Policosanol and tocotrienols (alternate forms of Vitamin E) for cholesterol reducing properties as a combination of unsaponifiable constitients.
The aforementioned 'unsaponifiable' constitients are merely a subset of the fatty acids which do not undergo saponification reactions (similar to soap making processes), in this scenario it is due to the sterols known as Gamma-Oryzanol being bound to a molecule known as Ferulic Acid; Gamma-Oryzanol is essentially a term used to refer to a collection of ferulated sterols.
Rice bran itself (10% of unprocessed rice by weight) is 18-22% oil, of which up to 5% is the unsaponifiable fraction. Due to this, the benefits associated with Gamma-Oryzanol may not be easily achieved with oral Rice Bran, due to Gamma-Oryzanol being at best 0.1% of Rice Bran by weight; Rice Brain Oil is plausible, but requires an oral dose of 6g to mimick 300mg Gamma-Oryzanol.
Gamma-oryzanol is a term used to refer to a collection of molecules build on a ferulic acid backbone, with 4-4'dimethylsterol or 4-desmethylsterol groups esterified to the ferulic acid. The compounds commonly referred to as Gamma-Oryzanol include:
Cycloartenol and Cycloartenyl Ferulate, the latter of which is seen as the primary ingredient
Beta-sitosterol (common in many plants)
The content of Gamma-Oryzanol varies depending on strain of rice, but tends to be around 244.1-342.6mg/kg with most content being attributed to cycloartenyl ferulate (27-30%) and 24-methylene cycloartenyl ferulate (53-57%).
Gamma-Oryzanol is a term used to refer to the above four molecules; fairly common structures but all bound to a Ferulic Acid molecule (and thus, Ferulated). The constitient molecules per se are not unique and are found in many vegetables, but are not too common when ferulated.
Gamma Oryzanol has demonstrated to pass through the skin membranes (transdermal application) when entrapped with Niosomes, transporter molecules composed of Tween 61 and cholesterol at equal ratios.
As Gamma Oryzanol is a collection of ferulated sterols, these molecules can be metabolized to provide circulating ferulic acid; with 300mg of Gamma-Oryzanol orally elevating serum levels of Gamma Oryzanol and Ferulic Acid on average to 37.6ng/mL and 36.6ng/mL, respectively. A later test noted that acute dosing of 600mg led to significant variability in serum Gamma-Oryzanol (21-106.8ng/mL), and that thrice daily dosing of 100mg was able to provide a relatively constant serum level of 111.7ng/mL.
Ferulic acid is excreted in the urine at 2.4-2.8% of the oral dose, with no detectable urinary Gamma-Oryzanol.
Repeated dosing may be more effective than single dosing, but pharmacokinetic data is limited
Gamma-Oryzanol, at 1-30ug/mL, failed to significantly inhibit CYP1A1/2, CYP2A6, CYP2B6, CYP2C8/9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4; with the most inhibitory potential being a mere 16% at 30ug/mL on CYP1A1/2.
Not yet found to inhibit any enzymes that would precede drug-drug interactions
One study in rats noted that there appeared to be preference for a diet containing Gamma-Oryzanol (high carb diet, via brown rice) in preference of a high fat diet. This was said to be possibly influenced by Gamma Oryzanol as injection of a chemical into they hypothalamis to reduce endoplasmic reticulum (ER) stress also induced preference for the high carb diet, and Gamma Oryzanol was found to control excess ER stress in high-fat fed rats and ER stress induced by a toxin. This study also noted suppression of a high-fat diet induced increase of TNF-a and IL-6 expression, normalizing the levels to that of the high carb control.
Some evidence that it may alter preference for food, with unknown potency or practical relevance; does not appear to really reduce food intake in animals
Gamma-Oryzanol is sometimes referred to as a supplement against symptoms of menopause.
The first studies to assess this claim noted that 1,500mg of gamma-oryzanol particulate (300mg total gamma-oryzanol) over 8 weeks was associated with improvements in menopausal symptoms in 90% of the study population (40% reporting the improvements as excellent) which has elsewhere been attributed to the ferulic acid content. More recently, thrice daily dosing of 20mg Gamma-Oryzanol has failed to outperform acupuncture (no control used in this study, and cited vicariously through two reviews as the full text cannot be located online).
The evidence to support gamma-oryzanol for usage in menopause is somewhat lacklustre, with one quite old study showing promising but the more recent study showing no benefit being underdosed. More research on this topic is needed
Gamma-Oryzanol appears to negatively influence the intestinal absorption of cholesterol directly, with high concentrations also impairing micelle formation. At 0.5% of the diet in rats, Gamma-Oryzanol can increase the amount of sterols and bile acids in the feces by 107% and 246%, respectively.
May reduce choleterol absorption, practical significance and potency relative to other cholesterol-inhibiting compounds is uncertain
Secondary to NF-kB inhibition (of which Gamma-Oryzanol components are moderately potent) one in vitro study noted that less inflammatory response from NF-kB resulted in less expression of adhesion molecules. Less VCAM-1 and E-selectin were expressed at 3uM while increasing the concentration to 30uM reduced both of those as well as ICAM-1; this led to less monocyte adhesion, reducing a 7-fold increase under inflammatory conditions to 1.7-fold under the influence of 30uM Gamma-Oryzanol, and was twice as effect as the control drug Pyrrolidine dithiocarbamate (PDTC)
Possesses anti-artherogenic properties secondary to it being anti-inflammatory
One study conducted in 30 hypercholesterolemic men with dietary guidance over 6 weeks were randomized to one of two Rice Bran Oils, varying in only their Gamma-Oryzanol content; one being low (50mg/50g; 0.1%) and the other high (800mg/50g; 1.6%). There was no significant difference between groups at any time-point.
This study noted a 11.9% reduction in LDL-C within two weeks of Rice Bran Oil, which was met with a slight reduction of HDL-C; there was a decrease in total cholesterol relative to baseline, but this decrease was met with peanut oil used as a control during dietary lead-in.
A diet consisting of 0.5% Gamma-Oryzanol in rats over 4 weeks was able to attenuate the rise in serum glucose concentrations induce by a high-fat diet secondary to increasing glycogen carbohydrate content and insulin levels. There was a suppression of G6Pase and PEPCK enzyme activity associated with Gamma-Oryzanol, and this was also seen with Ferulic Acid at 0.5% at similar potency.
One rat study noted a lesser AUC of insulin in a rat group fed 0.525% Gamma-Oryzanol, but no influence on glucose AUC or either glucose or insulin response to an intraperitoneal glucose tolerance test.
May benefit glucose metabolism secondary to its Ferulic Acid components, unknown practical relevance
A 9 week resistance training program in 22 recreationally active males was sufficient to reduce skinfold measurements while increasing body mass, with the addition of daily 500mg Gamma-Oryzanol failing to be significantly different than placebo. This study did not measure power output.
No notable benefits with Gamma-Oryzanol and physical performance
Gamma-Oryzanol (specifically Cycloartenyl Ferulate, 24-methyene Cyloartenylferulate, and B-Sitosteryl Ferulate) can inhibit NF-kB translocation in LPS-stimulated Macrophages at a concentration of 10ng/mL, with Cycloartenyl Ferulate reducing translocation of NF-kB to below 20% at 10ng/mL with other components between 20-40%. This inhibition has subsequently been noted in endothelial cells, reducing the LPS-induced NF-kB translocation down to 12.5% at 30uM Gamma-Oryzanol, which was more potent than the active control drug Pyrrolidine dithiocarbamate (PDTC).
The ferulated saponins are actually quite potent in vitro on one of the prototypical mechanisms of inflammation; NF-kB translocation. At nanogram concentrations is more effective than Feverfew and becomes slightly less effective at higher (10-30ug/mL) concentrations; both are quite effective at this mechanism
One study in rats with implanted colonic tumors who were fed either 0.2, 0.5, or 1% Gamma-Oryzanol orally for 2 weeks noted an increase in NK cell activity by 130%, 170%, and 220% above control when measuring splenic NK cell activity.
Appears to increase NK cell activity, unknown mechanisms; not remarkable potent when compared to other nutraceuticals
Gamma-Oryzanol at oral doses of 0.2, 0.5, or 1% of the diet for 2 weeks was able to increase activity of macrophages that were suppressed by the presence of a colonic tumor with 1% of the diet increasing the activity seen in tumor planted mice (50% or so) to 80% of control (when assessing nitric oxide release) and normalization of phagocytosis. This was accompanied by preservation of TNF-a, IL-b, and IL-1b.
Gamma-Oryzanol appears to be able to regulate angiogenesis, suppressing blood vessel formation in tumor implanted mice by 61% at 1% of the diet.
Gamma-Oryzanol is able to reduce melanin concentration in B16F1 Melanoma cells, by 13% at 3uM and 38% at 30uM; this correlated highly with a reduction in PKA activity that reduced microphthalmia-associated transcription factor (MTIF) which reduces melanin synthesis. A downregulation of Tyrosinase protein content and mRNA was also noted.
One rat study assessing components of Rice Bran (Gamma-Oryzanol, Ferulic Acid, Tocotrienols, or Phytic Acid all at 0.2%) noted that after implantation of a colonic tumor in mice, all compounds reduced tumor size slightly but Gamma-Oryzanol (and to a degree, Phytate) was most effective. Testing doses of 0.2, 0.5, and 1% of the diet led to dose-dependent reductions in colonic tumor size in these rats, with 1% reducing the tumor size by 44% yet 10% Rice Bran (used as an active control) reduced size by 7%.
Gamma Oryzanol can be applied topically when trapped in Niosomes (Tween 61:Cholesterol transport molecule) and, after 28 days of application, is associated with improvements on skin hydration (in about a third of subjects) and skin lightening (in 90% of subjects).
It has been noted that a supercritical carbon extraction of rice bran itself (Oryza sativa) appears to be able to inhibit the 5α reductase type I enzyme, suggesting it may increase testosterone and reduce DHT concentrations in the body. Subsequently, 500mg of gamma-oryzanol has been tested in healthy male athletes alongside a weight training program and failed to influence testosterone concentrations.
Does not appear to cause an increase in testosterone concentrations
9 weeks of 500mg daily Gamma-Oryzanol combined with a resistance training program in 22 healthy male athletes failed to significantly influence estrogen levels.
9 weeks of 500mg daily Gamma-Oryzanol combined with a resistance training program in 22 healthy male athletes failed to significantly influence circulating levels of growth hormone.
9 weeks of 500mg daily Gamma-Oryzanol combined with a resistance training program in 22 healthy male athletes failed to significantly influence cortisol.
Adiponectin is a hormone secreted by fat tissue, and known as an adipokine that increases insulin sensitivity; its decrease with obesity is correlated with an increase in insulin resistance. Its oral administration to mice appears to increase adiponectin in circulation, yet incubating an adipocyte (fat cell) with Gamma-Oryzanol fails to induce secretion of adiponectin.
An animal study that reduced circulating adiponectin levels with palmitate (a fatty acid) and beef tallow fed to rats noted that Gamma-Oryzanol (0.025mmol) was able to preserve adiponectin levels under the influence of palmitate and acted to increase circulating adiponectin in control (corn oil). As palmitate activates NF-kB which then acts to suppress adiponectin secretion from mouse 3T3-L1 adipocytes secondary to binding to PPARy and inhibiting its genomic actions, it is possible that these observed effects are secondary to Gamma-Oryzanol inhibiting NF-kB.
It was later confirmed that Gamma-Oryzanol (290mcg/kg) was able to increase adiponectin levels, and alongside GABA (also found in rice bran, 600mcg/kg) there appeared to be slightly better effects, but did not appear to be significantly synergistic.
Appears to increase Adiponectin in animals, which may be secondary to preventing a decline of adiponectin and thus causing a relative increase; which is greater than control animals